John Johnson, Director: Xeris Biopharma Holdings XERS Planned sale · Filed 25/08/13

Trade details

Type: Planned sale notice
Stock: Xeris Biopharma Holdings XERS
Person: John JohnsonDirector
Planned sale date: 25/08/13
Filed: 25/08/13

$786.5K to be sold

Xeris Biopharma Holdings trades, last 26 weeks

What else happened in Xeris Biopharma Holdings around then

Filed or reported within 30 days of the trade day · 25/07/14~25/09/12

John Johnson's recent trades

John JohnsonDirector
Sell10b5-1 planXeris Biopharma Holdings
Sell10b5-1 plan
Xeris Biopharma Holdings
XERS
$91.4K
15,000 sh
$91.4K
Filed 06/05
Traded 06/04
John JohnsonDirector
Planned sale10b5-1 planXeris Biopharma Holdings
Planned sale10b5-1 plan
Xeris Biopharma Holdings
XERS
$88.4K
15,000 sh
$88.4K
Filed 06/04
Traded 06/04
John JohnsonDirector
SellAxogen
Sell
Axogen
AXGN
$478K
11,050 sh
$478K
Filed 05/08
Traded 05/07
John JohnsonDirector
Planned saleAxogen
Planned sale
Axogen
AXGN
$478K
11,050 sh
$478K
Filed 05/07
Traded 05/07
John JohnsonDirector
Planned saleXeris Biopharma Holdings
Planned sale
Xeris Biopharma Holdings
XERS
$977K
135,402 sh
$977K
Filed 25/12/19
Traded 25/12/19

John Johnson, Director — plans to sell 107,500 sh of Xeris Biopharma Holdings XERS · $786.5K · around 08/13 | Whalegun